Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3115184rdf:typepubmed:Citationlld:pubmed
pubmed-article:3115184lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:3115184lifeskim:mentionsumls-concept:C0475358lld:lifeskim
pubmed-article:3115184lifeskim:mentionsumls-concept:C0086045lld:lifeskim
pubmed-article:3115184lifeskim:mentionsumls-concept:C0024623lld:lifeskim
pubmed-article:3115184lifeskim:mentionsumls-concept:C0001563lld:lifeskim
pubmed-article:3115184lifeskim:mentionsumls-concept:C0016360lld:lifeskim
pubmed-article:3115184lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:3115184lifeskim:mentionsumls-concept:C1446539lld:lifeskim
pubmed-article:3115184pubmed:issue9lld:pubmed
pubmed-article:3115184pubmed:dateCreated1987-10-8lld:pubmed
pubmed-article:3115184pubmed:abstractTextSerum and tumor tissue concentration of FT, 5-FU and uracil were measured in 23 patients with gastric cancer who were administered UFT preoperatively. The degeneration of cancer cells was evaluated histologically and the correlation between 5-FU concentration in the tumor tissue and the antitumor effect was assessed. The average concentration of 5-FU in tumor tissue (0.122 microgram/g) was significantly higher than that in normal gastric tissues. Serum 5-FU concentration was very low, suggesting no accumulation of 5-FU in blood. A positive correlation between the concentration of 5-FU and uracil in tumor tissues was found. A 5-FU level higher than 0.05 microgram/g was frequently demonstrated in tumor tissue, resulting in moderate degeneration of cancer cells in many cases. When tumors were classified according to histological type, intratumoral 5-FU concentration was not always correlated with degeneration of cancer cells. The above results suggested that UFT was a very effective drug for stomach cancer because of high tumor affinity for 5-FU, but that it is necessary to consider the sensitivity of tumor cells to antitumor drugs in order to obtain an excellent antitumor effect.lld:pubmed
pubmed-article:3115184pubmed:languagejpnlld:pubmed
pubmed-article:3115184pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3115184pubmed:citationSubsetIMlld:pubmed
pubmed-article:3115184pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3115184pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3115184pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3115184pubmed:statusMEDLINElld:pubmed
pubmed-article:3115184pubmed:monthSeplld:pubmed
pubmed-article:3115184pubmed:issn0385-0684lld:pubmed
pubmed-article:3115184pubmed:authorpubmed-author:OkaSSlld:pubmed
pubmed-article:3115184pubmed:authorpubmed-author:AokiYYlld:pubmed
pubmed-article:3115184pubmed:authorpubmed-author:FukunagaHHlld:pubmed
pubmed-article:3115184pubmed:authorpubmed-author:KawaguchiTTlld:pubmed
pubmed-article:3115184pubmed:authorpubmed-author:YukawaHHlld:pubmed
pubmed-article:3115184pubmed:authorpubmed-author:KatsumiMMlld:pubmed
pubmed-article:3115184pubmed:authorpubmed-author:KonishiRRlld:pubmed
pubmed-article:3115184pubmed:authorpubmed-author:TamakiYYlld:pubmed
pubmed-article:3115184pubmed:authorpubmed-author:TakifujiKKlld:pubmed
pubmed-article:3115184pubmed:issnTypePrintlld:pubmed
pubmed-article:3115184pubmed:volume14lld:pubmed
pubmed-article:3115184pubmed:ownerNLMlld:pubmed
pubmed-article:3115184pubmed:authorsCompleteYlld:pubmed
pubmed-article:3115184pubmed:pagination2735-9lld:pubmed
pubmed-article:3115184pubmed:dateRevised2010-11-18lld:pubmed
pubmed-article:3115184pubmed:meshHeadingpubmed-meshheading:3115184-...lld:pubmed
pubmed-article:3115184pubmed:meshHeadingpubmed-meshheading:3115184-...lld:pubmed
pubmed-article:3115184pubmed:meshHeadingpubmed-meshheading:3115184-...lld:pubmed
pubmed-article:3115184pubmed:meshHeadingpubmed-meshheading:3115184-...lld:pubmed
pubmed-article:3115184pubmed:meshHeadingpubmed-meshheading:3115184-...lld:pubmed
pubmed-article:3115184pubmed:meshHeadingpubmed-meshheading:3115184-...lld:pubmed
pubmed-article:3115184pubmed:meshHeadingpubmed-meshheading:3115184-...lld:pubmed
pubmed-article:3115184pubmed:meshHeadingpubmed-meshheading:3115184-...lld:pubmed
pubmed-article:3115184pubmed:meshHeadingpubmed-meshheading:3115184-...lld:pubmed
pubmed-article:3115184pubmed:meshHeadingpubmed-meshheading:3115184-...lld:pubmed
pubmed-article:3115184pubmed:meshHeadingpubmed-meshheading:3115184-...lld:pubmed
pubmed-article:3115184pubmed:meshHeadingpubmed-meshheading:3115184-...lld:pubmed
pubmed-article:3115184pubmed:year1987lld:pubmed
pubmed-article:3115184pubmed:articleTitle[5-FU concentration in tumor tissue and the antitumor effect in patients with gastric cancer after oral administration of UFT].lld:pubmed
pubmed-article:3115184pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:3115184pubmed:publicationTypeEnglish Abstractlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3115184lld:pubmed